Want to see TNXP full AI Analyst Report?
Tonix Pharma (TNXP) Income Statement
Tonix Pharma Income Statement
Last quarter (Q2 2026), Tonix Pharma's total revenue was $13.54M, an increase of 577.88% from the same quarter last year. In Q2, Tonix Pharma's net income was $-40.55M. See Tonix Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 13.11M | $ 10.09M | $ 7.77M | $ 0.00 | $ 0.00 | |
| $ 4.54M | $ 2.33M | $ 3.03M | $ 0.00 | $ 0.00 | |
| $ 130.25M | $ 139.03M | $ 121.41M | $ 112.09M | $ 92.31M | |
| Depreciation and Amortization | $ 1.93M | $ 3.42M | $ 4.29M | $ 1.25M | $ 50.00K |
| $ -122.01M | $ -74.32M | $ -112.37M | $ -108.97M | $ -92.24M | |
| $ -125.70M | $ -136.70M | $ -118.38M | $ -112.09M | $ -92.31M | |
| $ 1.68M | $ 6.67M | $ 1.72M | $ 1.87M | $ 25.00K | |
| $ -124.02M | $ -130.04M | $ -116.66M | $ -110.22M | $ -92.29M | |
| $ -124.02M | $ -130.04M | $ -116.66M | $ -110.22M | $ -92.29M | |
| Per Share Metrics | |||||
| Basic EPS | $ -14.57 | $ -176.60 | $ -6368.84 | $ -811.68 | $ -163968.00 |
| Diluted EPS | $ -14.57 | $ -176.60 | $ -6368.84 | $ -811.68 | $ -163968.00 |
| Weighted Average Shares Outstanding | 8.51M | 2.26M | 1.83M | 3.07M | 563 |
| Weighted Average Shares Outstanding (Diluted) | 8.51M | 2.26M | 1.83M | 3.07M | 563 |
Currency in USD
